Inovio Pharmaceuticals Q3 2020 Earnings Preview

• Inovio Pharmaceuticals (NASDAQ:INO) is scheduled to announce Q3 earnings results on Monday, November 9th, after market close.
• The consensus EPS Estimate is -$0.19 (+24.0% Y/Y) and the consensus Revenue Estimate is $3.05M (+250.6% Y/Y).
• Over the last 1 year, INO has beaten EPS estimates 0% of the time and has beaten revenue estimates 0% of the time.
• Over the last 3 months, EPS estimates have seen 0 upward revisions and 5 downward. Revenue estimates have seen 0 upward revisions and 2 downward.
• https://seekingalpha.com/news/3633410-inovio-pharmaceuticals-q3-2020-earnings-preview